Evidence map›Paper›PMID 38779774›Full record

ReviewHuman molecular genetics2024

RNA degradation in human mitochondria: the journey is not finished.

Giulia Santonoceto, Aneta Jurkiewicz, Roman J Szczesny

Abstract readReview
In one paragraph

Review in Human molecular genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Development of Mathematical Models Using circRNA Combinations (International journal of molecular sciences · 2025
    Article
  12. Article
  13. Mitochondrial RNA in Inflammation.International journal of biological sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giulia SantonocetoInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5A, Warsaw 02-106, Poland.ORCID 0009-0008-3345-7046
Aneta JurkiewiczInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5A, Warsaw 02-106, Poland.ORCID 0000-0003-2123-4255
Roman J SzczesnyInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5A, Warsaw 02-106, Poland.ORCID 0000-0002-0686-1632

Funding

Marie Skłodowska-Curie 101072515National Science Center, Poland 2021/42/E/NZ2/00442
6 · The paper itself

Abstract

Mitochondria are vital organelles present in almost all eukaryotic cells. Although most of the mitochondrial proteins are nuclear-encoded, mitochondria contain their own genome, whose proper expression is necessary for mitochondrial function. Transcription of the human mitochondrial genome results in the synthesis of long polycistronic transcripts that are subsequently processed by endonucleases to release individual RNA molecules, including precursors of sense protein-encoding mRNA (mt-mRNA) and a vast amount of antisense noncoding RNAs. Because of mitochondrial DNA (mtDNA) organization, the regulation of individual gene expression at the transcriptional level is limited. Although transcription of most protein-coding mitochondrial genes occurs with the same frequency, steady-state levels of mature transcripts are different. Therefore, post-transcriptional processes are important for regulating mt-mRNA levels. The mitochondrial degradosome is a complex composed of the RNA helicase SUV3 (also known as SUPV3L1) and polynucleotide phosphorylase (PNPase, PNPT1). It is the best-characterized RNA-degrading machinery in human mitochondria, which is primarily responsible for the decay of mitochondrial antisense RNA. The mechanism of mitochondrial sense RNA decay is less understood. This review aims to provide a general picture of mitochondrial genome expression, with a particular focus on mitochondrial RNA (mtRNA) degradation.

Indexed as

MitochondriaPolyribonucleotide NucleotidyltransferaseRNA, MitochondrialRNA StabilityDEAD-box RNA HelicasesDNA, MitochondrialEndoribonucleasesExoribonucleasesHumansMitochondrial ProteinsMultienzyme ComplexesRNARNA, AntisenseRNA HelicasesRNA, MessengerDEAD-box RNA HelicasesdegradosomeDNA, MitochondrialEndoribonucleasesExoribonucleasesMitochondrial ProteinsMultienzyme ComplexesPNPT1 protein, humanPolyribonucleotide NucleotidyltransferaseRNARNA, AntisenseRNA HelicasesRNA, MessengerRNA, MitochondrialSUPV3L1 protein, humanmitochondrial gene expressionmitochondrial RNA decaymitochondrial RNA surveillancepolyadenylation

Identifiers

PMID38779774
PMCPMC11497605

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.